This week we’re pod-swapping with our friends over at The Cannabis Enigma podcast by Cannigma.
This episode features Dr. Joseph Morgan, Professor of Cannabis Education at University of The Sciences, Pennsylvania, USA. We explore the role of cannabis in addiction treatment, the problems that federal law poses to medical cannabis research, and cannabis treatment protocol for addiction.
Check out The Cannabis Enigma Podcast by Cannigma now: https://cannigma.com/podcast/
→ View full show notes, summary, and access resources from this episodehere:
About Dr. Morgan
Joseph J. Morgan, MD, AACM is a Professor of Cannabis Education at the oldest pharmacy school in the U.S.A., founded as Philadelphia College of Pharmacy in 1822 and now known as University of the Sciences. He is the author of the chapter on addiction in the reference book “Cannabis As Medicine” (CRC Press, Taylor and Francis). He’s also an advisor to Parea Bio Sciences, a grower processor in Pennsylvania, and to Undoo.com, marketer of an antidote for cannabis intoxication. A longtime cannabis industry consultant, he has a patent pending in cannabinoid drug development licensed to Nexien Bio Pharma.
CBD will reduce cravings, whether it’s for cigarettes, whether it’s for heroin or cocaine. THC has impacts on the endogenous opioid system to get the body to release its own opioids like endorphins and enkephalins, which will help with withdrawal. 16:20
Modern FDA approved medicines have moved to single APIs. Herbal medicine, including cannabis, has hundreds of APIs, active pharmaceutical ingredients, so to get it FDA-approved, you have to do some level of toxicology and safety studies on each of the chemical constituents. 33:00
Join The Cannigma on LinkedIn: https://www.linkedin.com/company/thecannigma/
Join The Cannigma on Twitter: https://twitter.com/thecannigma
Follow The Cannigma on Instagram: https://www.instagram.com/thecannigma/
Subscribe to The Cannabis Enigma Podcast: https://podcasts.apple.com/il/podcast/the-cannabis-enigma/id1481452395